- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04413071
Cardiac COVID-19 Health Care Workers (CCC)
Cardiac Involvement in Coronavirus (SARS-Cov-2) Infected Health Care Workers: The CCC Study
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
Most people infected with SARS-CoV-2 experience mild, self-limiting symptoms that have been managed in an outpatient setting and therefore have not undergone routine cardiac evaluation with EKG or cardiac imaging test. Similarly, although the emphasis has been placed on evaluating patients with severe respiratory symptoms, most of these patients have also not undergone cardiac imaging tests and; therefore, in both scenarios, possible myocarditis has not routinely evaluated.
The present study is designed to characterize cardiac involvement in individuals who have overcome the SARS-CoV-2 infection.
For that aim, the study is designed as an observational cross-sectional study. The target population are HUSA healthcare workers who have overcome SARS-CoV-2 infection, either symptomatic or asymptomatic, either having required hospital admission or not. Participants will undergo a clinical evaluation, electrocardiogram (EKG), cardiac magnetic resonance (CMR) and blood analysis including NT-proBNP, troponin, cellular and humoral immunity and genetics.
Main objectives of the study are to address the prevalence of myocardial damage suggestive of myocarditis and to address the prevalence of pericarditis in HUSA health care workers; both related to the systemic immune response to SARS-CoV-2 infection. As secondary objectives the study will further address other cardiac affections including: rhythm or conduction disorders, ischemic heart disease, dilatation of the right chambers, valve disease and will analyze the relationship between humoral and cellular immunity and the presence of cardiac involvement, and the genetic susceptibility in the development of cardiac involvement after SARS-CoV-2 infection.
The study will recruit 141 participants: 47 symptomatic hospitalized health care workers, 47 asymptomatic non-hospitalized health care workers, 47 asymptomatic health care workers
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Salamanca, Spanien, 37007
- University Hospital of Salamanca
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Have overcome the SARS-CoV-2 infection meeting any of the following criteria (i) positive result on a reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay of a specimen collected on a nasopharyngeal swab followed by a second negative RT-PCR and at least 14 days from this negative RT-PCR; (ii) presence of IgM antibodies and negative RT-PCR after the antibody assessment; (iii) presence of neutralizing IgG antibodies and absence of IgM.
- stable clinical situation, which allows performing a CMR.
- signature of informed consent.
Exclusion Criteria:
- Presence of IgM antibodies without negative subsequent RT-PCR.
- Contraindications to perform RMC: (i) gadolinium allergy, (ii) presence of metallic material in the body, such as plates, screws, incompatible pacemakers, etc. (iii) claustrophobia, (iv) severe kidney failure, (v) severe liver failure, (vi) sickle cell anemia
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Tværsnit
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Health care workers
Health care workers from the University Hospital of Salamanca who have passed SARS-CoV-2 infection.
|
This is an observational design.
Participants have passed infection from SARS-CoV-2 and a cardiac assessment is performed.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Myocarditis
Tidsramme: up to 3 months
|
Prevalence of myocardial damage suggestive of myocarditis assessed by cardiac magnetic resonance
|
up to 3 months
|
|
Pericarditis
Tidsramme: up to 3 months
|
Prevalence of pericarditis assessed by clinical criteria
|
up to 3 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Atrial fibrillation
Tidsramme: up to 3 months
|
Prevalence of atrial fibrillation on EKG
|
up to 3 months
|
|
Ischemic heart disease
Tidsramme: up to 3 months
|
Prevalence of ischemic heart disease assessed by cardiac magnetic resonance
|
up to 3 months
|
|
Dilatation of right heart chambers
Tidsramme: up to 3 months
|
Prevalence of dilatation of right heart chambers assessed by cardiac magnetic resonance
|
up to 3 months
|
|
Valvular hear disease
Tidsramme: up to 3 months
|
Prevalence of valvular heart disease assessed by cardiac magnetic resonance
|
up to 3 months
|
|
Rhythm disorders
Tidsramme: up to 3 months
|
Prevalence of prolonged QT interval on EKG
|
up to 3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Hjertesygdomme
- Hjerte-kar-sygdomme
- Coronaviridae infektioner
- Nidovirales infektioner
- RNA-virusinfektioner
- Virussygdomme
- Infektioner
- Luftvejsinfektioner
- Luftvejssygdomme
- Lungebetændelse, viral
- Lungebetændelse
- Lungesygdomme
- Medfødte abnormiteter
- Kardiomyopatier
- Kardiovaskulære abnormiteter
- COVID-19
- Coronavirus infektioner
- Myokarditis
- Hjertefejl, medfødt
Andre undersøgelses-id-numre
- CCC_2020
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med COVID-19
-
PfizerAktiv, ikke rekrutterendeCOVID-19 | Coronavirus sygdom 2019 (COVID-19) | Covid-19-infektion | Vacciner mod covid-19 | SARS-CoV-2-infektion, COVID19 | COVID-19-vaccination | SARS-CoV-2-infektion, COVID-19 | COVID-19 (Coronavirus sygdom 2019) | COVID-19 SARS-CoV-2-infektionForenede Stater
-
PfizerRekrutteringLuftvejssygdomme | COVID-19 | Lungebetændelse | Lungesygdomme | Coronavirussygdom 2019 | Coronavirus sygdom 2019 (COVID-19) | Covid-19-infektion | Øvre luftvejsinfektioner | Luftvejsinfektion | COVID-19 (Coronavirus sygdom 2019) | COVID-19 SARS-CoV-2-infektionBelgien
-
Shanghai Public Health Clinical CenterIkke rekrutterer endnu
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Afsluttet
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RekrutteringTilstand efter COVID-19 | Efter COVID-19 | Post COVID-19 syndrom | Langt COVID-19 syndrom | Post COVID-19 tilstand (PCC)Tyskland
-
Yang I. PachankisAktiv, ikke rekrutterendeCOVID-19 luftvejsinfektion | COVID-19 stresssyndrom | COVID-19-vaccinebivirkning | COVID-19-associeret tromboembolisme | COVID-19 Post-Intensive Care Syndrome | COVID-19-associeret slagtilfældeKina
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico og andre samarbejdspartnereAfsluttetPostakutte følgesygdomme af COVID-19 | Tilstand efter COVID-19 | Langtids-COVID | Kronisk COVID-19 syndromItalien
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Aktiv, ikke rekrutterendeCovid-19 testadfærdForenede Stater
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRekrutteringTræthed | Post-COVID-19 syndrom | Tilstand efter COVID-19 | Post-COVID syndrom | Lang COVID-19 | Langtids-COVID | Post-COVID tilstandCanada
-
RSUP PersahabatanAfsluttetPost COVID-19 syndrom | Langt COVID-19 syndrom | Post COVID-syndrom Long CovidIndonesien
Kliniske forsøg med Passed infection of SARS-CoV-2
-
Istituto Clinico HumanitasRekruttering
-
Kern Medical CenterAfsluttetCOVID-19 | Sociale determinanter for sundhed | Penetrerende skadeForenede Stater
-
Manchester University NHS Foundation TrustAfsluttetCOVID-19 | CoronavirusinfektionDet Forenede Kongerige
-
National Institute for Medical Research, TanzaniaUniversity of Kinshasa (UNIKIN), Congo, The Democratic Republic of the... og andre samarbejdspartnereIkke rekrutterer endnu
-
Kern Medical CenterAfsluttetCOVID-19 | Postoperative komplikationer | Kirurgiske resultaterForenede Stater
-
University of Maryland, BaltimoreAfsluttetCOVID-19 | SARS-CoV2-infektionForenede Stater
-
SciensanoKU Leuven; University of Liege; Universiteit AntwerpenAktiv, ikke rekrutterendeCovid19 | SARS-CoV-2 infektionBelgien
-
Chita State Regional Clinical Hospital Number 1RekrutteringCoronavirusinfektion | Lungebetændelse, viralDen Russiske Føderation
-
National Institute of Allergy and Infectious Diseases...Johns Hopkins University; New York University Langone HealthAfsluttetLevertransplantationsmodtagere | NyretransplantationsmodtagereForenede Stater
-
Children's Oncology GroupRekruttering